Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.36B
Enterprise Value3.16B
P/E Ratio18.14
PEG Ratio-2.95
Price/Sales Ratio4.36
Price/Book Ratio2.41
Enterprise/Revenue4.08
Enterprise/EBITDA11.47

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.23
Operating Margin0.27
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.14

Income Statement

Revenue812.35M
Revenue/Share2.62
Gross Profit567.01M
EBITDA322.38M
Net Income195.12M
Diluted EPS0.61

Balance Sheet

Total Cash268.78M
Total Cash/Share0.85
Total Debt38.01M
Total Debt/Equity0.03
Current Ratio1.74
Book Value Per Share4.61

Price History

52-Week Change23.24
52-Week High16.97
52-Week Low8.9
Moving Average 50 Days11.38
Moving Average 200 Days11.68

Statistics

Average Volume6.45M
Shares Outstanding327.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield2.27
Payout Ratio0.42
Last Split Factor7:5
Last Split DateJune 08, 2023
AD